12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Iqvia Holdings Inc. (IQV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Harris Associates Natixis Global Asset Management | 11,335,677 | $2,227,573,884 | +12% | 2.93% |
| 2. | Farallon Capital Thomas Steyer | 3,123,151 | $613,730,403 | -2% | 3.11% |
| 3. | Cantillon Capital Management William Von Mueffling | 2,066,144 | $406,017,957 | +13% | 2.45% |
| 4. | Millennium Management Israel Englander | 1,370,570 | $269,330,711 | +302% | 0.13% |
| 5. | D E Shaw D. E. Shaw | 965,302 | $189,691,496 | +212% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $200.58 | 1,275 | Director | 1,275 | 2024-12-03 | Filing | |
| $262.82 | 4 | Officer | 26,228 | 2021-09-23 | Filing | |
| $245.32 | 13 | Officer | 20,355 | 2021-07-20 | Filing | |
| $272.93 | 10,000 | Director | 24,344 | 2021-12-22 | Filing | |
| $176.95 | 63,451 | Director | 137,410 | 2020-12-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $246.33 | 1,300 | Officer | 19,536 | 2024-08-27 | Filing | |
| $251.03 | 15,417 | Officer, Director | 796,752 | 2024-03-01 | Filing | |
| $250.05 | 16,261 | Officer, Director | 812,169 | 2024-03-01 | Filing | |
| $249.08 | 2,068 | Officer | 15,945 | 2024-02-29 | Filing | |
| $248.33 | 3,062 | Officer | 18,013 | 2024-02-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,474 | $3,433,266 | 0.52% | |
| 2. | 943 | $166,251 | 0% | |
| 3. | 118 | $20,803 | 0.01% |
News See All
IQVIA Holdings (IQV) Fell on Lowered Guidance
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” fourth quarter 2024, investor letter. A copy of the letter can be downloaded here.
IQVIA Holdings Inc. (NYSE:IQV) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Fourth Quarter 2024 Earnings Conference Call.
35 Non-Tech AI Opportunities Amid DeepSeek Selloff
Investors are searching for safer ways to capitalize on the AI boom beyond traditional tech stocks.
IQVIA Holdings (IQV) Fell Due to Reduced Near-Term Outlook in its R&D Solutions
Oakmark Funds, advised by Harris Associates, released its “Oakmark Select Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
IQVIA Holdings Inc. (NYSE:IQV) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Third Quarter 2024 Earnings Conference Call.
UBS' Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks
When it comes to investing and making massive gains on the stock market, disruption is the name of the game. The biggest firms on the market right now are all disruptors of their industries.
10 Trending AI Health Stocks
According to Statista Market Insights, the worldwide artificial intelligence (AI) market is projected to reach a size of $184 billion in 2024.
IQVIA Holdings Inc. (NYSE:IQV) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Second Quarter 2024 Earnings Conference Call.
Will IQVIA Holdings (IQV) Bounce Back?
Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
